CORC

在结果中检索

CORC

浏览/检索结果: 共182条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1
作者:  Zhang, Wei;  Gao, Yuhuan;  Jin, Zhengming;  Zhou, Jianfeng;  Jin, Chuan
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma : a multicentre, single-arm, phase 2 trial 期刊论文
The Lancet Haematology, 2019, 卷号: Vol.6 No.1, 页码: e12-e19
作者:  Yuankai Shi;  Hang Su;  Yongping Song;  Wenqi Jiang;  Xiuhua Sun
收藏  |  浏览/下载：39/0  |  提交时间：2019/02/25
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma 期刊论文
2019
作者:  An Gang;  Yan Yuting;  Xu Yan;  Mao Xuehan;  Liu Jiahui
收藏  |  浏览/下载：71/0  |  提交时间：2020/01/03
The impact of response kinetics for multiple myeloma in the era of novel agents 期刊论文
2019, 卷号: 3, 期号: 19, 页码: 2895-2904
作者:  Yan Yuting;  Mao Xuehan;  Liu Jiahui;  Fan Huishou;  Du Chenxing
收藏  |  浏览/下载：29/0  |  提交时间：2020/01/03
Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenstrom's Macroglobulinemia 期刊论文
2019, 卷号: 25, 期号: 1, 页码: 201-209
作者:  Hao, Mu;  Barlogie, Bart;  Tricot, Guido;  Liu, Lanting;  Qiu, Lugui
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
2019, 卷号: 6, 期号: 1, 页码: E12-E19
作者:  Shi, Yuankai;  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua
收藏  |  浏览/下载：19/0  |  提交时间：2020/01/03
Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study 期刊论文
2019, 卷号: 60, 期号: 9, 页码: 2122-2133
作者:  Horvath Noemi;  Spencer Andrew;  Kenealy Melita
收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03
Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas 会议论文
作者:  Zhu, Jun;  Cao, Junning;  Qiu, Lugui;  Qi, Junyuan;  Song, Yuqin
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study 期刊论文
CANCER MEDICINE, 2018, 卷号: 7, 期号: 4, 页码: 1043-1055
作者:  Huang, Xiaojun;  Qiu, Lugui;  Jin, Jie;  Zhou, Daobin;  Chen, Xiequn
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11
Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia 期刊论文
CELL RESEARCH, 2018, 卷号: 28, 期号: 2
作者:  Huang, Liang;  Liu, Dan;  Wang, Na;  Ling, Shaoping;  Tang, Yuting
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace